The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin
Open accessAbstract
Aminoglycosides can readthrough premature termination codons (PTCs), permitting translation of full-length proteins. Previously we have found variable efficiency of readthrough in response to the aminoglycoside gentamicin among cystic fibrosis (CF) patients, all carrying the W1282X nonsense mutation. Here we demonstrate that there are patients in whom the level of CF transmembrane conductance regulator (CFTR) nonsense transcripts is markedly reduced, while in others it is significantly higher. Response to gentamicin was found only in patients with the higher level. We further investigated the possibility that the nonsense-mediated mRNA decay (NMD) might vary among cells and hence governs the level of nonsense transcripts available for readthrough. Our results demonstrate differences in NMD efficiency of CFTR transcripts carrying the W1282X mutation among different epithelial cell lines derived from the same tissue. Variability was also found for 5 physiologic NMD substrates, RPL3, SC35 1.6 kb, SC35 1.7 kb, ASNS, and CARS. Importantly, our results demonstrate the existence of cells in which NMD of all transcripts was efficient and others in which the NMD was less efficient. Downregulation of NMD in cells carrying the W1282X mutation increased the level of CFTR nonsense transcripts and enhanced the CFTR chloride channel activity in response to gentamicin. Together our results suggest that the efficiency of NMD might vary and hence have an important role in governing the response to treatments aiming to promote readthrough of PTCs in many genetic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
Nagy, E., & Maquat, L. E. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01208-0 · Cited by 1,187
Lewis, B. P., Green, R. E., & Brenner, S. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136770100 · Cited by 1,067
Nonsense-mediated mRNA decayin health and disease
Frischmeyer, P. A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1893 · Cited by 992
Mendell, J. T., Sharifi, N. A., Meyers, J. L., Martinez-Murillo, F., & Dietz, H. C. (2004) · Nature Genetics · doi:10.1038/ng1429 · Cited by 876
Nonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu-Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 596
Self-citationAn mRNA Surveillance Mechanism That Eliminates Transcripts Lacking Termination Codons
Frischmeyer, P. A., van Hoof, A., O'Donnell, K., Guerrerio, A. L., Parker, R., & Dietz, H. C. (2002) · Science · doi:10.1126/science.1067338 · Cited by 590
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
Barton-Davis, E. R., Cordier, L., Shoturma, D. I., Leland, S. E., & Sweeney, H. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7866 · Cited by 585
Wilschanski, M., Yahav, Y., Yaacov, Y., Blau, H., Bentur, L., Rivlin, J., Aviram, M., Bdolah-Abram, T., Bebok, Z., Shushi, L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022170 · Cited by 503
Self-citationLeeds, P., Peltz, S. W., Jacobson, A., & Culbertson, M. R. (1991) · Genes & Development · doi:10.1101/gad.5.12a.2303 · Cited by 502
Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
Howard, M., Frizzell, R. A., & Bedwell, D. M. (1996) · Nature Medicine · doi:10.1038/nm0496-467 · Cited by 493
Highsmith, W. E., Burch, L. H., Zhou, Z., Olsen, J. C., Boat, T. E., Spock, A., Gorvoy, J. D., Quittell, L., Friedman, K. J., Silverman, L. M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311503 · Cited by 441
He, F., Li, X., Spatrick, P., Casillo, R., Dong, S., & Jacobson, A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00446-5 · Cited by 417
MANUVAKHOVA, M., KEELING, K., & BEDWELL, D. M. (2000) · RNA · doi:10.1017/s1355838200000716 · Cited by 404
Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line
Bedwell, D. M., Kaenjak, A., Benos, D. J., Bebok, Z., Bubien, J. K., Hong, J., Tousson, A., Clancy, J. P., & Sorscher, E. J. (1997) · Nature Medicine · doi:10.1038/nm1197-1280 · Cited by 343
Gene products that promote mRNA turnover in Saccharomyces cerevisiae.
Leeds, P., Wood, J. M., Lee, B. S., & Culbertson, M. R. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.5.2165 · Cited by 341
RUBENSTEIN, R. C., & ZEITLIN, P. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9706088 · Cited by 340
Gehring, N. H., Kunz, J. B., Neu-Yilik, G., Breit, S., Viegas, M. H., Hentze, M. W., & Kulozik, A. E. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.012 · Cited by 329
Self-citationCarter, M. S., Doskow, J., Morris, P., Li, S., Nhim, R. P., Sandstedt, S., & Wilkinson, M. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28995 · Cited by 329
SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs
Sureau, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1785 · Cited by 310
A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 Infection
Zeitlin, P. L., Lu, L., Rhim, J., Cutting, G., Stetten, G., Kieffer, K. A., Craig, R., & Guggino, W. B. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/4.4.313 · Cited by 303
Y14 and hUpf3b Form an NMD-Activating Complex
Gehring, N. H., Neu-Yilik, G., Schell, T., Hentze, M. W., & Kulozik, A. E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00142-4 · Cited by 291
Self-citationGentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations
Wagner, K. R., Hamed, S., Hadley, D. W., Gropman, A. L., Burstein, A. H., Escolar, D. M., Hoffman, E. P., & Fischbeck, K. H. (2001) · Annals of Neurology · doi:10.1002/ana.1023 · Cited by 272
Separable Roles for rent1/hUpf1 in Altered Splicing and Decay of Nonsense Transcripts
Mendell, J. T., ap Rhys, C. M. J., & Dietz, H. C. (2002) · Science · doi:10.1126/science.1074428 · Cited by 260
Immortalization and transformation of primary human airway epithelial cells by gene transfer
Lundberg, A. S., Randell, S. H., Stewart, S. A., Elenbaas, B., Hartwell, K. A., Brooks, M. W., Fleming, M. D., Olsen, J. C., Miller, S. W., Weinberg, R. A., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205550 · Cited by 258
CLANCY, J. P., BEBÖK, Z., RUIZ, F., KING, C., JONES, J., WALKER, L., GREER, H., HONG, J., WING, L., MACALUSO, M., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.2004001 · Cited by 253
Trapnell, B. C., Chu, C. S., Paakko, P. K., Banks, T. C., Yoshimura, K., Ferrans, V. J., Chernick, M. S., & Crystal, R. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6565 · Cited by 232
Burke, J. F., & Mogg, A. E. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.17.6265 · Cited by 218
WILSCHANSKI, M., FAMINI, C., BLAU, H., RIVLIN, J., AUGARTEN, A., AVITAL, A., KEREM, B., & KEREM, E. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9904116 · Cited by 212
Self-citationShoshani, T., Augarten, A., Gazit, E., Bashan, N., Yahav, Y., Rivlin, Y., Tal, A., Seret, H., Yaar, L., & Kerem, E. (1992) · Europe PMC (PubMed Central) · Cited by 199
Self-citationEvidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-Phenylbutyrate
Zeitlin, P. L., Diener-West, M., Rubenstein, R. C., Boyle, M. P., Lee, C. K. K., & Brass-Ernst, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0639 · Cited by 194
Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype
Yankaskas, J. R., Haizlip, J. E., Conrad, M., Koval, D., Lazarowski, E., Paradiso, A. M., Rinehart, C. A., Sarkadi, B., Schlegel, R., & Boucher, R. C. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.5.c1219 · Cited by 193
A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition
Noensie, E. N., & Dietz, H. C. (2001) · Nature Biotechnology · doi:10.1038/88099 · Cited by 187
Mitrovich, Q. M., & Anderson, P. (2000) · Genes & Development · doi:10.1101/gad.819900 · Cited by 186
Molecular basis for dominantly inherited inclusion body beta-thalassemia.
Thein, S. L., Hesketh, C., Taylor, P., Temperley, I. J., Hutchinson, R. M., Old, J. M., Wood, W. G., Clegg, J. B., & Weatherall, D. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3924 · Cited by 185
Du, M., Jones, J. R., Lanier, J., Keeling, K. M., Lindsey, R. J., Tousson, A., Bebök, Z., Whitsett, J. A., Dey, C. R., Colledge, W. H., et al. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0363-1 · Cited by 181
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results.
Politano, L., Nigro, G., Nigro, V., et al. (2003) · PubMed · Cited by 171
Keeling, K. M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.291 · Cited by 165
Bidou, L., Hatin, I., Perez, N., Allamand, V., Panthier, J., & Jp, R. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302211 · Cited by 163
Lai, C.-H., Chun, H. H., Nahas, S. A., Mitui, M., Gamo, K. M., Du, L., & Gatti, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405155101 · Cited by 163
Farmen, S. L., Karp, P. H., Ng, P., Palmer, D. J., Koehler, D. R., Hu, J., Beaudet, A. L., Zabner, J., & Welsh, M. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00049.2005 · Cited by 155
Keeling, K. M., & Bedwell, D. M. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-001-0317-z · Cited by 155
Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
Kerr, T. P., Sewry, C. A., Robb, S. A., & Roberts, R. G. (2001) · Human Genetics · doi:10.1007/s004390100598 · Cited by 142
Bateman, J. F. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg054 · Cited by 139
Wolstencroft, E. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi131 · Cited by 135
Alternative splicing and nonsense-mediated mRNA decay regulate mammalian ribosomal gene expression
Cuccurese, M., Russo, G., Russo, A., & Pietropaolo, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki905 · Cited by 129
Readthrough of dystrophin stop codon mutations induced by aminoglycosides
Howard, M. T., Anderson, C. B., Fass, U. W., Khatri, S., Gesteland, R. F., Atkins, J. F., & Flanigan, K. M. (2004) · Annals of Neurology · doi:10.1002/ana.20052 · Cited by 125
Negamycin Restores Dystrophin Expression in Skeletal and Cardiac Muscles of mdx Mice
Arakawa, M. (2003) · The Journal of Biochemistry · doi:10.1093/jb/mvg203 · Cited by 122
Dupuit, F., Kälin, N., Brézillon, S., Hinnrasky, J., Tümmler, B., & Puchelle, É. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118199 · Cited by 111
Nasal potential difference measurements in patients with atypical cystic fibrosis
Wilschanski, M. A., Famini, H., Strauss‐Liviatan, N., Rivlin, J., Blau, H., Bibi, H., Bentur, L., Yahav, Y., Springer, H., Kramer, M. R., et al. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00092501 · Cited by 107
Self-citationFRAMESHIFT SUPPRESSION IN SACCHAROMYCES CEREVISIAE. II. GENETIC PROPERTIES OF GROUP II SUPPRESSORS
Culbertson, M. R., Underbrink, K. M., & Fink, G. R. (1980) · Genetics · doi:10.1093/genetics/95.4.833 · Cited by 102
Morrison, M., Harris, K. S., & Roth, M. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9782 · Cited by 92
Martin, R., Mogg, A. E., Heywood, L. A., Nitschke, L., & Burke, J. F. (1989) · Molecular and General Genetics MGG · doi:10.1007/bf02464911 · Cited by 92
Sangkuhl, K., Schulz, A. M., Römpler, H., Yun, J. S., Wess, J., & Schöneberg, T. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh105 · Cited by 90
Hein, L. K., Bawden, M. J., Muller, V. J., Sillence, D. O., Hopwood, J. J., & Brooks, D. A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.012 · Cited by 86
A Phase I Trial of Intranasal Moli1901 for Cystic Fibrosis
Zeitlin, P. L., Boyle, M., Guggino, W. B., & Molina, L. (2004) · CHEST Journal · doi:10.1378/chest.125.1.143 · Cited by 73
Sleat, D. E., Sohár, I., Gin, R. M., & Lobel, P. (2001) · European Journal of Paediatric Neurology · doi:10.1053/ejpn.2000.0436 · Cited by 67
Zsembery, Á., Jessner, W., Sitter, G., Spirlì, C., Strazzabosco, M., & Graf, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30423 · Cited by 56
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis*
McCarty, N. A., Standaert, T. A., Teresi, M., Tuthill, C. W., Launspach, J. L., Kelley, T. J., Milgram, L. J. H., Hilliard, K. A., Regelmann, W. E., Weatherly, M. R., et al. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10041 · Cited by 49
In vitro analysis of aminoglycoside therapy for the Arg120stop nonsense mutation in RP2 patients
Grayson, C., Chapple, J. P., Willison, K. R., Webster, A. R., Hardcastle, A. J., & Cheetham, M. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.1.62 · Cited by 42
Nonstop treatment of cystic fibrosis
Dietz, H. C., & Hamosh, A. (1996) · Nature Medicine · doi:10.1038/nm0696-608b · Cited by 4
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
Veit, G., Avramescu, R. G., Chiang, A. N., Houck, S. A., Cai, Z., Peters, K. W., Hong, J. S., Pollard, H. B., Guggino, W. B., Balch, W. E., et al. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0935 · Cited by 580
Ratjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Kerem, E., Hirawat, S., Armoni, S., Yaakov, Y., Shoseyov, D., Cohen, M., Nissim-Rafinia, M., Blau, H., Rivlin, J., Aviram, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61168-x · Cited by 403
Self-citationIvanov, P. V., Gehring, N. H., Kunz, J. B., Hentze, M. W., & Kulozik, A. E. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.17 · Cited by 331
Self-citationTherapeutics Based on Stop Codon Readthrough
Keeling, K. M., Xue, X., Gunn, G., & Bedwell, D. M. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153527 · Cited by 306
Metadata
- Authors
- Linde, L., Boelz, S., Nissim-Rafinia, M., Oren, Y. S., Wilschanski, M., Yaacov, Y., Virgilis, D., Neu-Yilik, G., Kulozik, A. E., Kerem, E., & Kerem, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 683-692
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2117472380
- Cited by
- 300
- References
- 62
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.